Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 5/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PARP15 | Q460N3 | 2/20 | 0.38 |
| ▸ | PARP14 | Q460N5 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | IKBKB | O14920 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15375555 | 0.90 | SMN1; SMN2 (0.44) | SMN1; SMN2MAOBMAPTL3MBTL1LMNA | |
| SCHEMBL15375503 | 0.88 | CD274 (0.44) | PARP10TDP1MAOBSCN9AL3MBTL1 | |
| SCHEMBL15375353 | 0.88 | FABP4 (0.47) | TDP1SMN1; SMN2MAOBMAPTHPGD | |
| SCHEMBL15375571 | 0.88 | PARP10 (0.47) | PARP10MAOBF2MAPTHPGD | |
| SCHEMBL15402066 | 0.85 | FFAR1 (0.41) | MAOBMAPTL3MBTL1ALDH1A1LMNA | |
| SCHEMBL15401969 | 0.85 | MAPT (0.40) | TDP1SMN1; SMN2MAOBMAPTHPGD | |
| SCHEMBL15375524 | 0.84 | KDM4E (0.50) | PARP10SMN1; SMN2MAOBF2MAPT | |
| SCHEMBL15401611 | 0.84 | ALDH1A1 (0.41) | PARP10TDP1SMN1; SMN2MAOBMAPT | |
| SCHEMBL27855165 | 0.81 | SCN9A (0.38) | PARP10SMN1; SMN2MAOBF2SCN9A | |
| SCHEMBL15375329 | 0.81 | PTGDR2 (0.46) | TDP1SMN1; SMN2MAPTHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2682382-B1 | Method for Producing Phenylacetamide Compound | SUMITOMO CHEMICAL CO (JP) | 2016-11-23 | — | — | EP | disclosed |
| EP-2662352-B1 | Method for Producing Phenylacetamide Compound | SUMITOMO CHEMICAL CO (JP) | 2016-11-09 | — | — | EP | disclosed |
| CN-103588657-B | The manufacture method of phenylacetyl amines | 住友化学株式会社 | 2016-06-22 | — | — | CN | disclosed |
| EP-2397459-B1 | METHOD FOR PRODUCING PHENYLACETAMIDE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2015-12-16 | — | — | EP | disclosed |
| CN-103641731-B | The manufacture method of phenylacetyl amine compound | SUMITOMO CHEMICAL CO., LTD. (JP) | 2015-10-28 | — | — | CN | disclosed |
| CN-103588657-A | Method for producing phenylacetamide compound | SUMITOMO CHEMICAL CO | 2014-02-19 | — | — | CN | disclosed |
| EP-2682382-A2 | Method for Producing Phenylacetamide Compound | Sumitomo Chemical Company, Limited (JP) | 2014-01-08 | — | — | EP | disclosed |
| US-8624062-B2 | Method for producing phenylacetamide compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-01-07 | — | — | US | disclosed |
| EP-2662352-A2 | Method for Producing Phenylacetamide Compound | Sumitomo Chemical Company, Limited (JP) | 2013-11-13 | — | — | EP | disclosed |
| US-20120193617-A1 | LOW-MOLECULAR COMPOUND, POLYMER, ELECTRONIC-DEVICE MATERIAL, COMPOSITION FOR ELECTRONIC DEVICE, ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC SOLAR CELL ELEMENT, DISPLAY AND LIGHTING | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-08-02 | — | — | US | disclosed |
| EP-2397459-A1 | METHOD FOR PRODUCING PHENYLACETAMIDE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2011-12-21 | — | — | EP | disclosed |
| US-20110295035-A1 | METHOD FOR PRODUCING PHENYLACETAMIDE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120193617-A1 | LOW-MOLECULAR COMPOUND, POLYMER, ELECTRONIC-DEVICE MATERIAL, COMPOSITION FOR ELECTRONIC DEVICE, ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC SOLAR CELL ELEMENT, DISPLAY AND LIGHTING | EPCAM, CDH1, THEM6 | PARP10 2865/4885TDP1 4312/4885SMN1; SMN2 4355/4885 |
| US-20110295035-A1 | METHOD FOR PRODUCING PHENYLACETAMIDE COMPOUND | MRPL21, AADAC, ARSA | PARP10 1441/4885TDP1 4654/4885SMN1; SMN2 4638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.